Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2018 Jul 4;57(32):10153–10157. doi: 10.1002/anie.201804831

Complete Switch of Reaction Specificity of an Aldolase by Directed Evolution In Vitro: Synthesis of Generic Aliphatic Aldol Products

Sebastian Junker 1, Raquel Roldan 2, Henk‐Jan Joosten 3, Pere Clapés 2, Wolf‐Dieter Fessner 1,
PMCID: PMC6099348  PMID: 29882622

Abstract

A structure‐guided engineering of fructose‐6‐phosphate aldolase was performed to expand its substrate promiscuity toward aliphatic nucleophiles, that is, unsubstituted alkanones and alkanals. A “smart” combinatorial library was created targeting residues D6, T26, and N28, which form a binding pocket around the nucleophilic carbon atom. Double‐selectivity screening was executed by high‐performance TLC that allowed simultaneous determination of total activity as well as a preference for acetone versus propanal as competing nucleophiles. D6 turned out to be the key residue that enabled activity with non‐hydroxylated nucleophiles. Altogether 25 single‐ and double‐site variants (D6X and D6X/T26X) were discovered that show useful synthetic activity and a varying preference for ketone or aldehyde as the aldol nucleophiles. Remarkably, all of the novel variants had completely lost their native activity for cleavage of fructose 6‐phosphate.

Keywords: biocatalysis, fructose-6-phosphate aldolase, HPTLC screening, protein engineering, stereoselectivity


Aldolases and transaldolases are specialized on sugar phosphates, yet they are highly interesting biocatalytic tools for chemical synthesis because of their precise stereoselectivity in the carboligation step and their activity under very mild reaction conditions.1, 2 For example, fructose‐6‐phosphate aldolase (FSA) from E. coli is a thermostable Class I enzyme, which reversibly catalyses the highly stereoselective addition of dihydroxyacetone (DHA) to d‐glyceraldehyde 3‐phosphate (d‐GA3P), resulting in the formation of d‐fructose 6‐phosphate (d‐Fru6P; Scheme 1).3, 4, 5 Like other aldolases, FSA accepts a broad range of aldehydes as the electrophilic aldol component.2, 5, 6 However, while most aldolases are quite specific for their nucleophilic substrate, FSA tolerates some structural variation of the DHA nucleophile and also converts hydroxyacetone, hydroxybutanone, and hydroxyethanal.6 Recently, we demonstrated that designed minimal mutations in the FSA active site could further open up the nucleophile tolerance for large ketols at least up to the size of 1‐hydroxyheptan‐2‐one.7 Upon lifting the absolute requirement for α‐hydroxylation in the ketol nucleophiles, residual activity with generic aliphatic ketone substrates could be detected for wild‐type FSA and its D6H variant by using a fluorogenic assay for aldol cleavage.8 For aldol synthesis, however, products from unsubstituted aliphatic nucleophiles (simple ketones and aldehydes) could only be isolated when applying l‐GA3P as the electrophile with catalysis by FSA(D6H), presumably because phosphorylation confers high substrate binding affinity.

Scheme 1.

Scheme 1

Native use of DHA nucleophile by wild‐type FSA and promiscuous tolerance for acetone of the D6H variant with phosphorylated aldehyde electrophiles.8 Catalyzed addition of unsubstituted nucleophiles (acetone, propanal) to generic aliphatic electrophiles is as yet unknown.

An aldolase with the ability to utilize generic aliphatic, non‐hydroxylated substrates both as electrophilic and nucleophilic components would constitute a highly flexible catalyst for a plethora of synthetic opportunities toward the construction of chiral building blocks by green chemistry principles. The range of addressable targets from such reactions, such as the homo aldol products of aldehydes (e.g., 4, 5), are common structural motifs in natural products like polyketides9 or terpenoids,10 but are also important as intermediates in the production of pharmaceuticals11 and industrial bulk chemicals such as the Guerbet‐type compounds.12 Here, we present the engineering by a directed evolution approach of novel FSA variants that selectively use acetone (1) or propanal (2) as nucleophilic substrates with high carboligation stereoselectivity.

From an inspection of the enzyme active site, using the X‐ray structure of FSA with a model of the d‐Fru6P substrate bound to the catalytic lysine (K85),8 it is evident that the 3‐OH group in the nucleophile moiety interacts with residue D6 through hydrogen bonding and loosely contacts the backbone amide group of N28 (Figure 1). D6 also forms a hydrogen bond with 5‐OH of Fru6P. In addition, T26 donates a hydrogen bond to D6, which aligns it for an optimal substrate interaction. Replacing these polar residues by hydrophobic ones would interrupt the stabilizing contacts and thereby should improve alternative binding of non‐hydroxylated nucleophiles such as acetone or aliphatic aldehydes. The side chain of N28, however, donates a hydrogen bond to the 4‐OH group, which stabilizes incipient oxyanion formation at the aldehyde carbonyl group upon aldol attack and renders mutation of N28 problematic.13

Figure 1.

Figure 1

PyMOL15 model of the active site of the wild‐type FSA from E. coli.8 The X‐ray structure of FSA (PDB ID:1l6w)4 was aligned with the D‐F6P liganded in a highly similar transaldolase complex (PDB ID: 3s1v).14 The “essential” 3‐OH group is highlighted by an arrow.

To limit the screening efforts, we tested individual rational replacements for a first orientation. Indeed, single variants D6A, D6L, D6E, and D6H8 were found to be active with acetone as nucleophile and GA3P as electrophile. Exploratory saturation N28X in FSA variants D6E, D6H, and D6L abolished activity.

Thus, simultaneous site‐saturation mutagenesis was performed on the two remaining sites. To reduce the library to a manageable size, a smart construction approach was followed by eliminating mutations unlikely to yield positive hits.16 A structure‐based sequence alignment for the aldolase superfamily from Bio‐prodict (3DM database)17 delivered the amino acid distribution at positions that are structurally conserved within the whole superfamily. By encoding only the 3DM‐derived subset instead of all 20 proteinogenic amino acids, the library size can be significantly reduced. While the D6/T26 motif is highly conserved, an analysis of the correlated mutation data18 of the 3DM database showed that there is a functional connectivity between the amino acids. Variations occur only at very low frequency. For example, the rates for the entire Tal family are A/I 19.85 %; A/L 9.25 %; D/A 0.27 %, and for FSA‐type enzymes are L/T 0.74 %; D/C 0.56 %; D/D, D/S, P/T, R/T each 0.19 %. Therefore, we created a combinatorial library where Asp6 was mutated by using the restricted SHH set coding for A, D, Q, E, H, L, P, and V, and T26 by using the VYT set coding for A, I, L, P, T, and V (8×6=48 variants requiring the screening of 200 clones for 95 % coverage).19 Additionally, unusual solutions revealed by the 3DM software tool, such as the uncommon but allowed variants D6A, D6L, and D6P, as well as D6A/T26I and D6A/T26L combinations, are included in this setting.

Library screening was performed with whole cells in aqueous medium containing a mixture of acetone and propanal (1/2=17:1, v:v) as competitive substrates. Although the aldehyde was essential to serve as the electrophile, the ketone proportion was strongly increased to compensate for its lower reactivity with the catalytic lysine. Samples were periodically analyzed by TLC for product formation. Roughly 55 % of the clones yielded one or two new product spots (Figure 2) with intensities stronger than wild‐type, whereas others barely produced detectable product amounts or were inactive.

Figure 2.

Figure 2

Exemplary TLC analysis using acetone and propanal as substrates catalyzed by hit‐plate candidates with different activity and nucleophile selectivity. Anisaldehyde staining reveals a blue spot corresponding to the homo‐aldol 4, and a green spot for the cross‐aldol 3. Lanes correspond to variant sequences: A=D6H, B=D6H/T26L, C=D=D6A/T26A (duplicate clone), E=T26I, F=wt, G=D6L/T26I, H=D6P/T26L. Image contrast was digitally improved for visualization.

Re‐screening and sequencing furnished a total set of 25 unique genetic variants. The latter were further characterized for their relative kinetic activities and for their substrate selectivity against 1 and 2 by automated high‐performance TLC (HPTLC) analysis using densitometrical product quantification. We found that HPTLC is a medium‐throughput screening method, which is well suited for the direct screening of aldol product formation, thereby allowing simultaneous analysis of both activity and selectivity. It is complementary to the typical inverse determination of aldolase activity by aldol cleavage assays3 albeit limited to endpoint measurements. The HPTLC method was validated by a comparison to standard GC results, using reactions catalyzed by FSA variants D6E, D6L, D6A, and D6L/T26A.

Among the 25 unique hits, 16 (64 %) showed a clear competitive preference for one over the other nucleophile (nucleophile preference >3:1), while the other 9 (36 %) produced both products 3 and 4 in similar quantities (Scheme 2). The 16 selective variants were further analyzed by GC for an accurate determination of their nucleophile selectivity (Figure 3). The analysis shows that the two positions (D6/T26) selected for mutagenesis are indeed the expected hot spots for changing the catalytic properties of the enzyme, and that the “smart library” strategy paid off with a very high proportion of positive hits (25 out of 48 library members, 52 % hit rate). The conditions chosen for substrate competition facilitated a direct evaluation of both activity and nucleophile selectivity, which could be read out using conventional medium‐throughput TLC screening.

Scheme 2.

Scheme 2

Reactions used for screening the nucleophile preference of the D6X/T26X library. Stereoselectivity was analyzed through cyclic acetal formation. Reaction conditions: i) NaBH4, MeOH ii) 2,2‐dimethoxypropane, H+.

Figure 3.

Figure 3

Activity and competitive nucleophile bias of selective FSA variants, in comparison to wild‐type and the D6E variant as a non‐selective example. Relative cumulative rates (GC peak sum for products 3+4) are based on most active variant D6L. Green bars indicate preference for 1 (major product 3) as the nucleophile, blue bars for 2 (major product 4).

Clearly, non‐hydroxylated nucleophiles become favored if the hydrogen‐bonding pattern directed at the 3‐OH group is deleted through non‐polar D6 replacement (D6A, D6V, D6L, D6P), or if mutant residues are incompatible with the hydrogen‐bonding network and occupy an additional volume (D6H, D6E, D6Q). While under the specific conditions, many active variants appeared rather non‐selective (e.g., D6E), some variants showed very high complementary selectivity for either of the aldehyde or ketone nucleophiles. A detailed analysis of the selective candidates revealed that the known D6H variant8 was the most selective catalyst for 1, similar to the more highly active D6L variant (Figure 3). However, most of the selective variants preferred the more reactive 2 as a nucleophile, despite of its much lower assay concentration. Interestingly, the primary preference introduced by the D6X replacement can be strongly shifted towards improved preference for 2 by T26X exchanges, particularly with residues with increasing hydrophobic volume (A≪V<L<I). The effect is observed for D6E, D6L, D6H, and is particularly effective for D6H, where a strong switch of preference from 1 (D6H) to 2 (D6H/T26L) takes place, which both show similar rates. A synonymous trend is seen for D6A or D6P but to a lesser extent because these are already quite selective for 2. While the T26V and T26I are mostly accompanied by lower rates, the T26L mutants typically show higher rate and thus represent the best choice with a compromise in rate and selectivity. The highest selectivity for 2 was determined for the D6Q/T26I variant but only at a rather low rate. Surprisingly, the simple T26L mutation alone results in significantly increased rate and selectivity for 2. Notably, proline is tolerated in the D6 position but is not tolerated to replace T26; usually, introduction of proline is cumbersome because of conformational restrictions.

The very high selectivity of several variants to utilize 2 as nucleophile was unexpected, given its low concentration in comparison to excessive 1. Separate experiments were conducted to determine relative catalytic activities in the absence of nucleophile competition, firstly by using 2 as the sole substrate (Figure 4, left); as a reference enzyme we used the DERA from E. coli (F200I variant20), which so far is the only enzyme known to accept 2 as a non‐native nucleophile.21 A complementary screen was performed by using 1 in the presence of an aldehyde electrophile (6) that itself is unreactive for self‐aldolization (Figure 4, right).

Figure 4.

Figure 4

Blue bars: rate of formation of 4 by self‐aldolization of 2 catalyzed by FSA variants most active in primary screenings; wt‐FSA and DERA from E. coli (light blue) were included for reference. Green bars: rate of formation of 11 by addition of 1 to 6 using FSA variants most active on 1. For reaction conditions see the Supporting Information.

In the first tests, most active FSA variants, independent of their nucleophile selectivity, were screened for their rate of formation of 4. The concentration of 2 had to be limited (83 mm) because of its denaturation effect on the enzyme at higher substrate concentrations. Whereas wild‐type FSA showed barely any detectable product formation, several variants displayed good activity. Several new FSA variants (D6A/T26A, D6A/T26V, D6E/T26A) were found to have activity superior to the DERA reference. A distinctive feature is that reactions catalyzed by FSA variants stop after the first addition to form 4, while DERA catalyzes a consecutive addition to give a trimer of type 5, which can cyclize into a lactol form.21

In the second test series, variants selective for 1 were investigated for their relative rates. As the electrophile, isopentanal (6) was employed when isobutanal proved unreactive with common nucleophiles; neither showed any reactivity for self‐aldolization even at high enzyme concentrations, probably because of their steric bulkiness. The corresponding aldol products are acyclic and generated by a bimolecular synthetic process, and are thus thermodynamically unfavorable,22 but acetone can be used at rather high concentration to drive the equilibrium towards product formation because FSA is quite stable to organic cosolvents. Screening for the formation of 7 under these non‐competitive conditions showed that only the single mutants D6L and D6H have high activity, whereas mutant combinations caused lower rates.

Unfortunately, for none of the reactions studied could we find a reliable in vitro assay to perform steady‐state kinetic measurements with purified enzymes in the direction of aldol synthesis. Probably owing to its low electrophilic nature, acetone has only low binding affinity to FSA and no KM could be estimated. Clearly, rate differences reported are not due to different expression levels, which were checked by SDS‐PAGE, nor to different protein stabilities, which were checked by differential scanning fluorimetry.7

The novel activities and selectivity are most likely due to an improved binding of hydrophobic nucleophiles because the main catalytic mechanism of the Class I aldolase, involving covalent Schiff base formation at K85 and tyrosine residues acting as an acid–base catalyst,22, 23 remains intact. A major effect is caused by replacements of D6 that interrupt the hydrogen‐bonding network for recognition of the 3‐OH group and occupy a larger space than the native aspartate (D6L, D6H, D6E, D6Q; except for D6A). In particular, D6H and D6L show good activity with 1, because the compact remaining space seems inappropriate to bind the larger alkyl moiety of 2. Considering the large excess of 1 in the assay solution, the collective data indicate that all other variants essentially have a preference for 2, which can be further enhanced by hydrophobic replacements of T26. Apparently, the side chain volumes of T26V, T26I and T26L restrict the most distant cavity space of the active site where C1 of the substrate is located. Thereby, binding of the C1 moiety of a ketone nucleophile becomes obstructed in favor of a smaller aldehyde moiety. Among the positive T26 variants, the T26L mutation seems to be the most adaptive, while T26I needs to be combined with D6A replacement to compensate for its steric bulkiness.

Stereoselectivity is a critical issue when the electrophile C=O is not firmly positioned and can be attacked from both faces.5 However, product 3 obtained on a preparative scale (34 % yield) showed high enantiomeric purity (ee >95 %) by GC with a chiral stationary phase.24 Similar results were obtained by preparative addition of 1 to 6 and to the straight‐chain isomer 8, yielding aldol products 7 and 9, respectively.

(2S)‐Configuration can be anticipated for steric reasons when using 2 as a nucleophile; however, since this was never rigorously proven for the corresponding DERA reaction,21 there was no reference available. Thus, product 4 obtained on a preparative scale (21 % yield) was converted into the cyclic derivative 10 for stereochemical analysis (Scheme 2). NMR analysis clearly demonstrated the cis‐(2S,3R) arrangement of the alkyl substituents, and GC analysis with a chiral stationary phase showed the presence of only a single enantiomer (>99 % ee). As a control, aldehyde 4 was exposed to alkaline conditions before being processed, which yielded a mixture of cis and trans diastereomers.25 Thus, the native (3S,4R)‐stereoselectivity of the wild‐type FSA was fully retained with non‐hydroxylated, hydrophobic substrate analogues. Gratifyingly, FSA variants D6A/T26L and D6A/T26I were even active with butanal (11) to form the aldol dimer 12 with about one third of the rate for 4 and with the same diastereoselectivity, as proven by a corresponding analysis of the derivative 13. The larger homologue 8 did not lead to aldol formation. Both compounds 4 and 12 are formal precursors to industrially important Guerbet‐type compounds, which are used as bulk solvents/plasticizers.12 It is tempting to speculate that enzymatic routes to such man‐made bulk materials26 could be realized using FSA‐derived catalysts in a biotechnology process.

In summary, by using a single smart library strategy, it was possible to identify a collection of new FSA variants with novel activities and distinct preferences for the nucleophilic substrate, which are promising for possible use in the stereospecific synthesis of chiral building blocks. These enzymes significantly expand the product space hitherto addressable by enzymatic carboligation.1, 2 Remarkably, the synthesis of all generic aldol products such as 3, 4, 7, 9 or 12—stripped from the abundant polar functionalization of native substrates—could also be performed conveniently using recombinant whole‐cell catalysis because such substrates and products seem to permeate quite well across the cell wall. It is appropriate to stress that all new enzyme variants completely lost the native FSA activity for cleavage of Fru6P, nor do they show residual synthetic activity with hydroxylated nucleophiles.

This study shows that a complete switch in reaction specificity of an aldolase can be realized by focusing directed evolution on a confined hot spot of substrate binding. By exploiting existing knowledge on enzyme structure–function relationships and exhaustive bioinformatic analysis of protein databases, smart combinatorial libraries can be rapidly designed that offer very high hit rates. We could also show that parallel, automated HPTLC analysis is a valuable medium‐throughput screening tool that is well suited for such a highly focused approach. We believe that the direct monitoring of product formation is more flexible, and furnishes more appropriate data for an evaluation of the synthetic capacity of carboligation catalysts, compared to the conventional indirect monitoring of fragments arising from aldol cleavage.

Conflict of interest

The authors declare no conflict of interest.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary

Acknowledgements

This project received funding from the European Union's Horizon 2020 research and innovation program under grant no. 635595 (CarbaZymes), the Spanish Ministerio de Economía y Competitividad (MINECO), and the Fondo Europeo de Desarrollo Regional (FEDER) (grant no. CTQ2015‐63563‐R to P.C.).

S. Junker, R. Roldan, H.-J. Joosten, P. Clapés, W.-D. Fessner, Angew. Chem. Int. Ed. 2018, 57, 10153.

References

  • 1. 
  • 1a. Brovetto M., Gamenara D., Saenz Mendez P., Seoane G. A., Chem. Rev. 2011, 111, 4346–4403; [DOI] [PubMed] [Google Scholar]
  • 1b. Müller M., Adv. Synth. Catal. 2012, 354, 3161–3174; [Google Scholar]
  • 1c. Windle C. L., Mueller M., Nelson A., Berry A., Curr. Opin. Chem. Biol. 2014, 19, 25–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. 
  • 2a. Clapés P., Fessner W.-D., Sprenger G. A., Samland A. K., Curr. Opin. Chem. Biol. 2010, 14, 154–167; [DOI] [PubMed] [Google Scholar]
  • 2b. Fessner W.-D., in Enzyme Catalysis in Organic Synthesis (3rd ed), Vol. 2, (Eds.: K. Drauz, H. Groeger, O. May), Wiley-VCH, Weinheim, 2011, pp. 857–917; [Google Scholar]
  • 2c. Clapés P., Garrabou X., Adv. Synth. Catal. 2011, 353, 2263–2283. [Google Scholar]
  • 3. Schürmann M., Sprenger G. A., J. Biol. Chem. 2001, 276, 11055–11061. [DOI] [PubMed] [Google Scholar]
  • 4. Thorell S., Schurmann M., Sprenger G. A., Schneider G., J. Mol. Biol. 2002, 319, 161–171. [DOI] [PubMed] [Google Scholar]
  • 5. Samland A. K., Rale M., Sprenger G. A., Fessner W.-D., ChemBioChem 2011, 12, 1454–1474. [DOI] [PubMed] [Google Scholar]
  • 6. 
  • 6a. Castillo J. A., Calveras J., Casas J., Mitjans M., Vinardell M. P., Parella T., Inoue T., Sprenger G. A., Joglar J., Clapés P., Org. Lett. 2006, 8, 6067–6070; [DOI] [PubMed] [Google Scholar]
  • 6b. Sugiyama M., Hong Z., Liang P.-H., Dean S. M., Whalen L. J., Greenberg W. A., Wong C.-H., J. Am. Chem. Soc. 2007, 129, 14811–14817; [DOI] [PubMed] [Google Scholar]
  • 6c. Concia A. L., Lozano C., Castillo J. A., Parella T., Joglar J., Clapés P., Chem. Eur. J. 2009, 15, 3808–3816; [DOI] [PubMed] [Google Scholar]
  • 6d. Garrabou X., Castillo J. A., Guérard-Hélaine C., Parella T., Joglar J., Lemaire M., Clapés P., Angew. Chem. Int. Ed. 2009, 48, 5521–5525; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2009, 121, 5629; [Google Scholar]
  • 6e. Rale M., Schneider S., Sprenger G. A., Samland A. K., Fessner W.-D., Chem. Eur. J. 2011, 17, 2623–2632. [DOI] [PubMed] [Google Scholar]
  • 7. Güclü D., Szekrenyi A., Garrabou X., Kickstein M., Junker S., Clapés P., Fessner W.-D., ACS Catal. 2016, 6, 1848–1852. [Google Scholar]
  • 8. Roldán R., Sanchez-Moreno I., Scheidt T., Hélaine V., Lemaire M., Parella T., Clapés P., Fessner W.-D., Guérard-Hélaine C., Chem. Eur. J. 2017, 23, 5005–5009. [DOI] [PubMed] [Google Scholar]
  • 9. Piel J., Nat. Prod. Rep. 2010, 27, 996–1047. [DOI] [PubMed] [Google Scholar]
  • 10. Ajikumar P. K., Tyo K., Carlsen S., Mucha O., Phon T. H., Stephanopoulos G., Mol. Pharm. 2008, 5, 167–190. [DOI] [PubMed] [Google Scholar]
  • 11. Patel J. M., J. Mol. Catal. B 2009, 61, 123–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Falbe J., Bahrmann H., Lipps W., Mayer D., Frey G. D., in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, 2013, pp. 1–26. [Google Scholar]
  • 13. Schörken U., Thorell S., Schürmann M., Jia J., Sprenger G. A., Schneider G., Eur. J. Biochem. 2001, 268, 2408–2415. [DOI] [PubMed] [Google Scholar]
  • 14. Lehwess-Litzmann A., Neumann P., Parthier C., Luedtke S., Golbik R., Ficner R., Tittmann K., Nat. Chem. Biol. 2011, 7, 678–684. [DOI] [PubMed] [Google Scholar]
  • 15.W. L. DeLano, Schrödinger LLC., 2002, http://www.pymol.org.
  • 16. Nobili A., Gall M. G., Pavlidis I. V., Thompson M. L., Schmidt M., Bornscheuer U. T., FEBS J. 2013, 280, 3084–3093. [DOI] [PubMed] [Google Scholar]
  • 17. Kuipers R. K., Joosten H.-J., van Berkel W. J. H., Leferink N. G. H., Rooijen E., Ittmann E., van Zimmeren F., Jochens H., Bornscheuer U., Vriend G., Martins dos Santos V. A. P., Schaap P. J., Proteins Struct. Funct. Bioinf. 2010, 78, 2101–2113. [DOI] [PubMed] [Google Scholar]
  • 18. van den Bergh T., Tamo G., Nobili A., Tao Y., Tan T., Bornscheuer U. T., Kuipers R. K. P., Vroling B., de Jong R. M., Subramanian K., Schaap P. J., Desmet T., Nidetzky B., Vriend G., Joosten H.-J., PLoS One 2017, 12, e0176427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Firth A. E., Patrick W. M., Nucleic Acids Res. 2008, 36, W281—W285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Jennewein S., Schuermann M., Wolberg M., Hilker I., Luiten R., Wubbolts M., Mink D., Biotechnol. J. 2006, 1, 537–548. [DOI] [PubMed] [Google Scholar]
  • 21. Gijsen H. J. M., Wong C.-H., J. Am. Chem. Soc. 1995, 117, 7585–7591. [Google Scholar]
  • 22. Zeymer C., Zschoche R., Hilvert D., J. Am. Chem. Soc. 2017, 139, 12541–12549. [DOI] [PubMed] [Google Scholar]
  • 23. Sautner V., Friedrich M. M., Lehwess-Litzmann A., Tittmann K., Biochemistry 2015, 54, 4475–4486. [DOI] [PubMed] [Google Scholar]
  • 24. Knorr A., Weissernborn A., US1714378, 1929.
  • 25. Häckh M., Müller M., Lüdeke S., Chem. Eur. J. 2013, 19, 8922–8928. [DOI] [PubMed] [Google Scholar]
  • 26. Biermann M., Bakonyi D., Hummel W., Groeger H., Green Chem. 2017, 19, 405–410. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary


Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES